Hakan Akbulut

2.4k total citations
138 papers, 1.7k citations indexed

About

Hakan Akbulut is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hakan Akbulut has authored 138 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 26 papers in Molecular Biology. Recurrent topics in Hakan Akbulut's work include Virus-based gene therapy research (14 papers), Cancer Treatment and Pharmacology (13 papers) and Immunotherapy and Immune Responses (12 papers). Hakan Akbulut is often cited by papers focused on Virus-based gene therapy research (14 papers), Cancer Treatment and Pharmacology (13 papers) and Immunotherapy and Immune Responses (12 papers). Hakan Akbulut collaborates with scholars based in Türkiye, United States and Italy. Hakan Akbulut's co-authors include K. Gonca Akbulut, Fikri İçlı, Yucheng Tang, Albert Deisseroth, Lixin Zhang, Abdullah Büyükçelik, Ahmet Demirkazık, Bülent Yalçın, Yüksel Ürün and Filiz Çay Şenler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hakan Akbulut

126 papers receiving 1.7k citations

Peers

Countries citing papers authored by Hakan Akbulut

Since Specialization

Citations

This map shows the geographic impact of Hakan Akbulut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Akbulut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Akbulut more than expected).

Fields of papers citing papers by Hakan Akbulut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakan Akbulut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Akbulut. The network helps show where Hakan Akbulut may publish in the future.

Co-authorship network of co-authors of Hakan Akbulut

This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Akbulut. A scholar is included among the top collaborators of Hakan Akbulut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Akbulut. Hakan Akbulut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	mRNA-based COVID-19 Vaccines Appear to not Increase Immune Events in Cancer Patients Receiving Immune Checkpoint Inhibitors 2021 ·Future Virology ·Emre Yekedüz, Rüveyda Ayasun, (unknown), Güngör Utkan, Yüksel Ürün, Hakan Akbulut	2
2	Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study 2021 ·The Turkish Journal of Gastroenterology ·Ulus Salih Akarca, Belkıs Ünsal, Orhan Sezgın, Kendal Yalçın, Meral Akdoğan, Can Gönen, Feyza Gündüz, Seren Özeni̇rler, Abdullah Sonsuz, Dinc Dinçer, Salim Başol Tekin, İdris Yücel, Hakan Akbulut, Canan Alkım, Özgür Özyılkan, (unknown), (unknown), Ramazan Idılman, (unknown), (unknown)	2
3	Immune gene therapy of cancer 2020 ·TURKISH JOURNAL OF MEDICAL SCIENCES ·Hakan Akbulut	18
4	1678P_PR The impact of COVID-19 pandemic on cancer care: A global collaborative study 2020 ·Annals of Oncology ·Abdul Rahman Jazieh, Hakan Akbulut, Giuseppe Curigliano, (unknown), Abdullah A. Alsharm, Evangelia Razis, Layth Mula‐Hussain, Hassan Errihani, Adnan Khattak, Roselle De Guzman, Clarissa Mathias, Mohammad Alkaiyat, Hoda Jradi, Christian Rolfo	5
5	The effects of melatonin and curcumin on the expression of SIRT2, Bcl-2 and Bax in the hippocampus of adult rats 2018 ·Brain Research Bulletin ·(unknown), K. Gonca Akbulut, (unknown), (unknown), (unknown), Hakan Akbulut	37
6	Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG) 2016 ·Supportive Care in Cancer ·Ali Alkan, (unknown), Filiz Çay Şenler, Tuğba Yavuzşen, (unknown), Mutlu Doğan, (unknown), (unknown), (unknown), Özgür Tanrıverdi, Serdar Turhal, Yüksel Ürün, (unknown), (unknown), Hakan Akbulut	19
7	Prognostic Importance of Bone Marrow Uptake on Baseline ¹⁸ F-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma 2016 ·Cancer Biotherapy and Radiopharmaceuticals ·Çiğdem Soydal, (unknown), (unknown), (unknown), Beyza Doğanay Erdoğan, Hakan Akbulut, (unknown)	7
8	The G8 Global Partnership: From Kananaskis to Deauville and Beyond 2013 ·Social Science Open Access Repository (GESIS – Leibniz Institute for the Social Sciences) ·Hakan Akbulut	1
9	Smoking Habits of Relatives of Patients with Cancer: Cancer Diagnosis in the Family is an Important Teachable Moment for Smoking Cessation 2013 ·Asian Pacific Journal of Cancer Prevention ·Mutlu Hayran, Saadettin Kılıçkap, (unknown), Hakan Akbulut, Hüseyin Abalı, Deniz Yüce, (unknown), Serdar Turhal	4
10	ABO and Rh blood groups frequency in women with HER2 positive breast cancer. 2012 ·PubMed ·(unknown), Güngör Utkan, Kadri Altundağ, Osman Şevki Arslan, (unknown), Ülkü Yalçıntaş Arslan, Murat Koçer, (unknown), Filiz Çay Şenler, Bülent Yalçın, Ahmet Demirkazık, Hakan Akbulut, (unknown)	6
11	Nuklear-radiologische Proliferation: Gefahrdungspotential und Praventionsmoglichkeiten fur Osterreich 2011 ·Social Science Open Access Repository (GESIS – Leibniz Institute for the Social Sciences) ·(unknown), Hakan Akbulut, (unknown), (unknown), (unknown), (unknown), (unknown)	1
12	The effect of age and Helicobacter pylori infection on gastric epithelial cell kinetics 2011 ·Clinics and Research in Hepatology and Gastroenterology ·Şahin Çoban, İrfan Soykan, Murat Törüner, Hakan Akbulut, Teslime Atlı, Arzu Ensarı	2
13	Vector Prime/Protein Boost Vaccine That Overcomes Defects Acquired during Aging and Cancer 2006 ·The Journal of Immunology ·Yucheng Tang, Hakan Akbulut, (unknown), (unknown), Xiangming Fang, Weiwei Zhang, Xiao-Qin Xia, James A. Koziol, Phyllis‐Jean Linton, Albert Deisseroth	12
14	Lamivudine prophylaxis for prevention of chemotherapy‐induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies 2004 ·Journal of Viral Hepatitis ·Ramazan Idılman, Mutlu Arat, Ender Soydan, Murat Törüner, (unknown), Hakan Akbulut, Önder Arslan, Muhıt Özcan, A.R. Türkyilmaz, Mithat Bozdayı, Selim Karayalçın, D H Van Thiel, A. Özden, Meral Beksaç, Hamdi Akan	72
15	An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells 2003 ·Proceedings of the National Academy of Sciences ·Lixin Zhang, Yucheng Tang, Hakan Akbulut, Daniel Zelterman, Phyllis‐Jean Linton, Albert Deisseroth	56
16	THE EFFECTS OF MELATONIN ON HUMORAL IMMUNE RESPONSES OF YOUNG AND AGED RATS 2001 ·Immunological Investigations ·K. Gonca Akbulut, Birgül Benli, Hakan Akbulut	30
17	Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma 2000 ·Cancer ·(unknown), Mustafa Samur, (unknown), (unknown), Hakan Akbulut, (unknown), (unknown), (unknown), (unknown), (unknown)	3
18	Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer 1999 ·British Journal of Cancer ·(unknown), Salim Demirci, (unknown), (unknown), Hakan Akbulut, Hasan Akgül, (unknown)	46
19	A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma 1998 ·Cancer ·(unknown), (unknown), (unknown), Nuri Faruk Aykan, (unknown), Ahmet Demirkazık, (unknown), (unknown), (unknown), Hakan Akbulut, (unknown)	29
20	A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5‐fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma 1998 ·Cancer ·Fikri İçlı, İ. Çelik, Nuri Faruk Aykan, (unknown), Ahmet Demirkazık, Ahmet Özet, (unknown), (unknown), Hakan Akbulut, D. Fırat	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact